Patient Preferences and Novel Regimens Incorporating GLP-1 RAs with Insulin

Program: CMES Ancillary Events
Session: CMES2-Applying the Evidence for GLP-1 Receptor Agonists in Type 2 Diabetes: Practice Perspectives
Clinical
Supported by an educational grant from AstraZeneca
Friday, March 6, 2015: 5:45 AM-8:00 AM
Presentation Start Time: 7:00 AM
Sapphire B (Hilton San Diego Bayfront)
Samuel Dagogo-Jack, MD, FRCP
University of Tennessee Health Science Center, Memphis, TN

Disclosure Not Provided: SD